SALIVARY DUCT CARCINOMA .2. IMMUNOHISTOCHEMICAL EVALUATION OF 13 CASES FOR ESTROGEN AND PROGESTERONE RECEPTORS, CATHEPSIN-D, AND C-ERB-2 PROTEIN

被引:67
作者
BARNES, L
RAO, U
CONTIS, L
KRAUSE, J
SCHWARTZ, A
SCALAMOGNA, P
机构
[1] UNIV PITTSBURGH, MED CTR, DEPT PATHOL, PITTSBURGH, PA 15260 USA
[2] TULANE UNIV, SCH MED, DEPT PATHOL, NEW ORLEANS, LA 70112 USA
来源
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY | 1994年 / 78卷 / 01期
关键词
D O I
10.1016/0030-4220(94)90120-1
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Salivary duct carcinoma is an infrequent highly aggressive salivary gland tumor that is histologically similar to ductal carcinoma of the breast. We studied 13 cases by immunohistochemistry for the presence of estrogen and progesterone receptors, cathepsin D, and c-erbB-2 protein to determine whether the similarity to breast carcinoma extended beyond the light microscope to the molecular level and, if so, whether these markers might have therapeutic or prognostic value. Twelve of 13 cases contained sufficient amounts of tumor tissue for evaluation. Of these 12 cases, one (8%) was positive for estrogen receptors, none was positive for progesterone receptors, five (42%) were positive for cathepsin D, and three (25%) were positive for c-erbB-2 protein. Expression of cathepsin D and c-erbB-2 protein does not appear to have prognostic significance in salivary duct carcinoma. The 8% incidence of immunopositivity for estrogen receptors and absence of progesterone receptors in salivary duct carcinoma is considerably less than that seen in breast cancer. Nevertheless, because the occurrence of systemic metastasis in salivary duct carcinoma is such an ominous development largely unresponsive to chemotherapy, antihormonal therapy, such as used in breast cancer, might be considered on a trial basis for those tumors that are estrogen receptor-positive when conventional therapeutic modalities fail.
引用
收藏
页码:74 / 80
页数:7
相关论文
共 44 条
[1]  
ALLRED DC, 1993, AM J CLIN PATHOL, V99, P1
[2]  
ALLRED DC, 1990, ARCH SURG-CHICAGO, V125, P107
[3]   QUANTITATION OF ESTROGEN AND PROGESTERONE RECEPTORS BY IMMUNOCYTOCHEMICAL AND IMAGE ANALYSES [J].
AZIZ, DC .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1992, 98 (01) :105-111
[4]  
BABIAK J, 1992, CANCER, V70, P770, DOI 10.1002/1097-0142(19920815)70:4<770::AID-CNCR2820700409>3.0.CO
[5]  
2-U
[6]   SALIVARY DUCT CARCINOMA .1. A CLINICOPATHOLOGICAL EVALUATION AND DNA IMAGE-ANALYSIS OF 13 CASES WITH REVIEW OF THE LITERATURE [J].
BARNES, L ;
RAO, U ;
KRAUSE, J ;
CONTIS, L ;
SCHWARTZ, A ;
SCALAMOGNA, P .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 1994, 78 (01) :64-73
[7]  
BATTIFORA H, 1991, MODERN PATHOL, V4, P466
[8]  
BERGER U, 1989, CANCER RES, V49, P5176
[9]  
CHARPIN C, 1988, CANCER RES, V48, P1578
[10]  
CHENG L, 1988, LAB INVEST, V58, P346